Series A - PostEra

Series A - PostEra

Investment Firm

Overview

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients

Announced Date

Jan 11, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Clermont Group

Clermont Group

Clermont Group is a early_stage_venture and private_equity and venture firm.

Participant Investors

7

Investor Name
Participant InvestorLifeforce Capital
Participant InvestorClermont Group
Participant InvestorHOF Capital
Participant InvestorMartin Chavez
Participant InvestorI2BF Global Ventures

Round Details and Background

PostEra raised $24000000 on 2022-01-11 in Series A

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 16, 2020
Seed Round - PostEra
2-150.0K
Mar 30, 2020
Seed Round - PostEra
2-2.3M
Jan 11, 2022
Series A - PostEra
8-24.0M
May 18, 2022
Grant - PostEra
1-undefined

Recent Activity

There is no recent news or activity for this profile.